CN108813501A - 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 - Google Patents
具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 Download PDFInfo
- Publication number
- CN108813501A CN108813501A CN201810521657.0A CN201810521657A CN108813501A CN 108813501 A CN108813501 A CN 108813501A CN 201810521657 A CN201810521657 A CN 201810521657A CN 108813501 A CN108813501 A CN 108813501A
- Authority
- CN
- China
- Prior art keywords
- grams
- honey
- health
- honeysuckle
- almond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000012907 honey Nutrition 0.000 title claims abstract description 212
- 230000036541 health Effects 0.000 title claims abstract description 97
- 206010011224 Cough Diseases 0.000 title claims abstract description 64
- 210000004072 lung Anatomy 0.000 title claims abstract description 46
- 208000006673 asthma Diseases 0.000 title claims abstract description 39
- 206010036790 Productive cough Diseases 0.000 title claims abstract description 24
- 210000003802 sputum Anatomy 0.000 title claims abstract description 18
- 208000024794 sputum Diseases 0.000 title claims abstract description 18
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 74
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 74
- 235000020224 almond Nutrition 0.000 claims abstract description 73
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 67
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 67
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 60
- 241001145025 Saussurea involucrata Species 0.000 claims abstract description 52
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 48
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 48
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 48
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 48
- 240000001987 Pyrus communis Species 0.000 claims abstract description 41
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 41
- 210000004369 blood Anatomy 0.000 claims abstract description 35
- 239000008280 blood Substances 0.000 claims abstract description 35
- 238000002360 preparation method Methods 0.000 claims abstract description 29
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 16
- 201000011510 cancer Diseases 0.000 claims abstract description 16
- 231100000614 poison Toxicity 0.000 claims abstract description 14
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 13
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 11
- 239000003440 toxic substance Substances 0.000 claims abstract description 11
- 150000002632 lipids Chemical class 0.000 claims abstract description 10
- 230000036039 immunity Effects 0.000 claims abstract description 9
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 8
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 8
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 230000017531 blood circulation Effects 0.000 claims abstract description 7
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 6
- 230000003356 anti-rheumatic effect Effects 0.000 claims abstract description 6
- 239000003435 antirheumatic agent Substances 0.000 claims abstract description 6
- 210000000987 immune system Anatomy 0.000 claims abstract description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims abstract description 6
- 230000003471 anti-radiation Effects 0.000 claims abstract description 5
- 230000036592 analgesia Effects 0.000 claims abstract description 4
- 230000005764 inhibitory process Effects 0.000 claims abstract description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 7
- 239000007788 liquid Substances 0.000 claims description 86
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- 235000019441 ethanol Nutrition 0.000 claims description 51
- 238000004321 preservation Methods 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 238000003756 stirring Methods 0.000 claims description 40
- 238000009835 boiling Methods 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 31
- 238000000605 extraction Methods 0.000 claims description 30
- 235000021433 fructose syrup Nutrition 0.000 claims description 26
- 238000002386 leaching Methods 0.000 claims description 25
- 230000002829 reductive effect Effects 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 11
- 239000013049 sediment Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 85
- 230000006872 improvement Effects 0.000 abstract description 5
- 241001570521 Lonicera periclymenum Species 0.000 description 87
- 230000006870 function Effects 0.000 description 49
- 239000003814 drug Substances 0.000 description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 30
- 235000013399 edible fruits Nutrition 0.000 description 27
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 26
- 235000013616 tea Nutrition 0.000 description 26
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 25
- 206010062717 Increased upper airway secretion Diseases 0.000 description 25
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 25
- 229940074393 chlorogenic acid Drugs 0.000 description 25
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 25
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 25
- 235000001368 chlorogenic acid Nutrition 0.000 description 25
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 25
- 201000010099 disease Diseases 0.000 description 25
- 208000026435 phlegm Diseases 0.000 description 25
- 235000009508 confectionery Nutrition 0.000 description 24
- 241001122767 Theaceae Species 0.000 description 23
- 239000000126 substance Substances 0.000 description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 22
- 239000000047 product Substances 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 238000011282 treatment Methods 0.000 description 17
- 241000196324 Embryophyta Species 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 241000220324 Pyrus Species 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 15
- -1 nitrogenous compound Chemical class 0.000 description 15
- 235000021017 pears Nutrition 0.000 description 15
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 14
- 229930091371 Fructose Natural products 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 13
- 241000700159 Rattus Species 0.000 description 13
- 229960002737 fructose Drugs 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 230000036407 pain Effects 0.000 description 13
- 230000001376 precipitating effect Effects 0.000 description 13
- 239000005715 Fructose Substances 0.000 description 12
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 12
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 11
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 150000003722 vitamin derivatives Chemical class 0.000 description 11
- 241000256844 Apis mellifera Species 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 10
- 208000025865 Ulcer Diseases 0.000 description 10
- 229930003268 Vitamin C Natural products 0.000 description 10
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- 231100000397 ulcer Toxicity 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 230000001151 other effect Effects 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- 230000035922 thirst Effects 0.000 description 9
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Chemical class 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 8
- 239000002253 acid Chemical class 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 229930182478 glucoside Natural products 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 210000000582 semen Anatomy 0.000 description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 230000013872 defecation Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 7
- 235000019410 glycyrrhizin Nutrition 0.000 description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 244000061508 Eriobotrya japonica Species 0.000 description 6
- 235000008100 Ginkgo biloba Nutrition 0.000 description 6
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 229940089837 amygdalin Drugs 0.000 description 6
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 230000001754 anti-pyretic effect Effects 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 5
- 206010018910 Haemolysis Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 230000000954 anitussive effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 235000019605 sweet taste sensations Nutrition 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 235000011201 Ginkgo Nutrition 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 239000004378 Glycyrrhizin Substances 0.000 description 4
- 206010018612 Gonorrhoea Diseases 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 239000005864 Sulphur Substances 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 229940099690 malic acid Drugs 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 4
- 229940096998 ursolic acid Drugs 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 3
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000040350 B family Human genes 0.000 description 3
- 108091072128 B family Proteins 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 description 3
- 241000345998 Calamus manan Species 0.000 description 3
- 241001672694 Citrus reticulata Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000017443 Hedysarum boreale Nutrition 0.000 description 3
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 3
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010061926 Purulence Diseases 0.000 description 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- JSNRRGGBADWTMC-UHFFFAOYSA-N alpha-farnesene Natural products CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 230000001088 anti-asthma Effects 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000021185 dessert Nutrition 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229930189775 mogroside Natural products 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 229940100243 oleanolic acid Drugs 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- VLXDPFLIRFYIME-QRTUWBSPSA-N (1S,2R,6R,7R,8S)-1,3-dimethyl-8-propan-2-yltricyclo[4.4.0.02,7]dec-3-ene Chemical compound C1C=C(C)[C@@H]2[C@@]3(C)CC[C@@H](C(C)C)[C@@H]2[C@H]31 VLXDPFLIRFYIME-QRTUWBSPSA-N 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 2
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- HEVGGTGPGPKZHF-UHFFFAOYSA-N 1-(1,2-dimethyl-3-methylidenecyclopentyl)-4-methylbenzene Chemical compound CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QNMKGMUGYVWVFQ-UHFFFAOYSA-N 2alpha-Hydroxyursolic acid Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3C(C)C(C)(C)CCC3(C(O)=O)CCC21C QNMKGMUGYVWVFQ-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 2
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 241000208671 Campanulaceae Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
- 241000133134 Saussurea Species 0.000 description 2
- 102000005686 Serum Globulins Human genes 0.000 description 2
- 108010045362 Serum Globulins Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 239000004870 Styrax Substances 0.000 description 2
- 244000028419 Styrax benzoin Species 0.000 description 2
- 235000000126 Styrax benzoin Nutrition 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003260 anti-sepsis Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- HFGSQOYIOKBQOW-ZSDYHTTISA-N corosolic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C HFGSQOYIOKBQOW-ZSDYHTTISA-N 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000032459 dedifferentiation Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- IPAVEOUAXMIIKX-UHFFFAOYSA-N eriobofuran Chemical compound C1=CC=C2C(C=C(C(=C3OC)O)OC)=C3OC2=C1 IPAVEOUAXMIIKX-UHFFFAOYSA-N 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930002886 farnesol Natural products 0.000 description 2
- 229940043259 farnesol Drugs 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical group 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 2
- 229960002646 scopolamine Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000001648 tannin Chemical class 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Chemical class 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000009916 yin-huang Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- SXFBQAMLJMDXOD-UHFFFAOYSA-N (+)-hydrogentartrate bitartrate salt Chemical compound OC(=O)C(O)C(O)C(O)=O.OC(=O)C(O)C(O)C(O)=O SXFBQAMLJMDXOD-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- JXBSHSBNOVLGHF-UHFFFAOYSA-N 10-cis-Dihydrofarnesen Natural products CC=C(C)CCC=C(C)CCC=C(C)C JXBSHSBNOVLGHF-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical compound C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010000383 Accidental poisoning Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000209134 Arundinaria Species 0.000 description 1
- 241000244185 Ascaris lumbricoides Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006542 Bulbar palsy Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000871264 Cardiospermum halicacabum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229930191892 Formycin Natural products 0.000 description 1
- KBHMEHLJSZMEMI-UHFFFAOYSA-N Formycin A Natural products N1N=C2C(N)=NC=NC2=C1C1OC(CO)C(O)C1O KBHMEHLJSZMEMI-UHFFFAOYSA-N 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- 241000592346 Ginkgophyta Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 1
- 241000114343 Lonicera caprifolium Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 241001504477 Pycnonotidae Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 235000016641 Syzygium paniculatum Nutrition 0.000 description 1
- 244000223082 Syzygium paniculatum Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- UNLRVSBRNJYNHN-UHFFFAOYSA-N [cyano-(3-phenoxyphenyl)methyl] 2-(4-chlorophenyl)-3-methylbutanoate;dimethoxy-(4-nitrophenoxy)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1.C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 UNLRVSBRNJYNHN-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 229960004266 acetylcholine chloride Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004855 amber Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003457 anti-vomiting effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005004 cholera vaccine Drugs 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000010159 dioecy Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- GFJIQNADMLPFOW-VNHYZAJKSA-N elemol Chemical compound CC(=C)[C@@H]1C[C@H](C(C)(C)O)CC[C@@]1(C)C=C GFJIQNADMLPFOW-VNHYZAJKSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- VEPYXRRTOARCQD-IGPDFVGCSA-N formycin Chemical compound N1=N[C]2C(N)=NC=NC2=C1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O VEPYXRRTOARCQD-IGPDFVGCSA-N 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000010758 granulomatous inflammation Diseases 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000002011 intestinal secretion Anatomy 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 239000008779 ma-xing-shi-gan-tang Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 235000016768 molybdenum Nutrition 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000826 nictitating membrane Anatomy 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000015206 pear juice Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 201000002241 progressive bulbar palsy Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical group 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008530 yinqiaosan Substances 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
Abstract
本发明涉及具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏。具体的,一方面涉及的养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜、秋梨、罗汉果、杏仁、白果、薄荷、金银花、甘草、枇杷叶、茶树花、雪莲培养物。还涉及该养生蜂蜜膏的制备方法,以及其在制备清热润肺止咳化痰平喘和调节人体机能的产品中的用途,例如在制备解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力的产品中的用途,例如在制备镇痛、抗炎、抗风湿、抑制血小板聚集、降血脂、改善血液循环、调节免疫系统、抗氧化、抗辐射、抗疲劳的产品中的用途。本发明养生蜂蜜膏具有如说明书所述优异技术效果。
Description
技术领域
本发明属于医药健康产品领域,涉及一种蜂蜜膏,特别是涉及一种养生蜂蜜膏,这种养生蜂蜜膏 具有清热润肺止咳化痰平喘和调节人体机能的功效。更特别地是涉及一种由蜂蜜、秋梨、罗汉果、杏 仁、白果、薄荷、金银花、甘草、枇杷叶、茶树花、雪莲培养物制成的具有清热润肺止咳化痰平喘和 调节人体机能的养生蜂蜜膏,该养生蜂蜜膏具有优异的生物学功能特别是治疗、预防和保健功能,具 有解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力、镇痛、抗炎、抗风湿、抑制血小板聚集、 降血脂、改善血液循环、调节免疫系统、抗氧化、抗辐射、抗疲劳等多方面的药效学作用。本发明还 涉及所述蜂蜜膏的制备方法,以及这些蜂蜜膏的医药用途。
背景技术
蜂蜜是蜜蜂采集植物花蜜酿成的一种理想的天然保健品。蜂蜜膏是以蜂蜜为主要原料并配以其他 食用和药用原料而制备的一种适用于各类人群食用的保健食品。随着人们生活水平的提高以及生活节 奏的加快,不同的人群多会表现出不同的亚健康的状态,例如便秘、肤质下降、高血压、骨质增生等, 同时也正因为生活水平的提高,人们也更加重视身体健康,并且为了减少药物而带来的副作用开始选 择保健类食品去维护身体健康。蜂蜜膏因便于食用且适用于各类人群,开始被越来多的人群所选择, 而由于不同人群对于蜂蜜膏的功能往往会有所差异,因此为满足市场需求而需要针对人们的不同需求 而生产相应功效的蜂蜜膏。
蜂蜜是蜜蜂采集植物花蜜酿成的天然保健品,其中包含:葡萄糖、果糖、酸类、酶类、维生素、 矿物质、蛋白质、芳香物质以及少量的色素、花粉、糖醇类、丹宁类、树脂等其它生物活性物质。其 中,葡萄糖和果糖在蜂蜜中占65%以上而赋予蜂蜜的甜味、吸湿性和能量的价值及有形的特征;维生 素主要来自蜂蜜中的花粉,并且以B族维生素最为丰富次是维生素C。常见的维生素有核黄素、吡多 酸(VB6)、烟酸、叶酸、抗坏血酸、生物素、生育酚等;蜂蜜中的矿物质含量和种类与人体血液中的 含量、种类十分相近易于人体吸收。
我国医学经典著作《神农本草经》中把蜂蜜列为药中之上品。中医认为蜂蜜性平味甘,入肺、脾、 大肠经,具有滑肠通便、入肺补中、缓急、解毒之功效。《本草纲目》称:“蜂蜜入药之功有五:清热 也;补中也;润燥也;解毒也;止痛也。生则性凉,故能解热;熟则性温,故能补中;甘而平和,故 能解毒;柔而濡津,故能润燥;缓可以去急,故能止心腹肌肉疮疡之痛;和可至中,故能调和百药, 而与甘草同功。蜂蜜在长时间的食用和药用过程中,根据实践人们发现蜂蜜对不同亚健康状态的人群 均会起到不同程度的缓急止痛、润肺止咳、润肠通便、润肤生肌、解毒等作用。
然而,本领域仍然需要提供一种养生蜂蜜膏特别是具有清热润肺止咳化痰平喘和调节人体机能的 养生蜂蜜膏。
发明内容
本发明的目的在于提供一种养生蜂蜜膏特别是具有清热润肺止咳化痰平喘和调节人体机能的养生 蜂蜜膏。本发明另一目的在于提供一种制备养生蜂蜜膏特别是具有清热润肺止咳化痰平喘和调节人体 机能的养生蜂蜜膏的方法。已经出人意料的发现,具有本发明配方的养生蜂蜜膏呈现优异的生物学效 应,并且本发明制备方法具有优异的膏剂配制效果。
为此,本发明第一方面提供了一种具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏,其 是由包括如下的组分制备得到的:蜂蜜、秋梨、罗汉果、杏仁、白果、薄荷、金银花、甘草、枇杷叶、 茶树花、雪莲培养物。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,秋梨的量为50~150克,例如80~120克, 例如100克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,罗汉果的量为20~100克,例如20~50 克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,杏仁的量为10~50克,例如10~30克, 例如20克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,白果的量为5~20克,例如5~10克,例 如7.5克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,薄荷的量为5~20克,例如5~10克,例 如7.5克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,金银花的量为20~100克,例如20~50 克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,甘草的量为5~30克,例如5~20克,例 如10克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,枇杷叶的量为20~100克,例如20~50 克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,茶树花的量为50~250克,例如50~150 克,例如100克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,雪莲培养物的量为20~100克,例如20~60 克,例如40克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨50~150 克、罗汉果20~100克、杏仁10~50克、白果5~20克、薄荷5~20克、金银花20~100克、甘草5~30 克、枇杷叶20~100克、茶树花50~250克、雪莲培养物20~100克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨80~120 克、罗汉果20~50克、杏仁10~30克、白果5~10克、薄荷5~10克、金银花20~50克、甘草5~20克、 枇杷叶20~50克、茶树花50~150克、雪莲培养物20~60克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨100 克、罗汉果30克、杏仁20克、白果7.5克、薄荷7.5克、金银花30克、甘草10克、枇杷叶30克、 茶树花100克、雪莲培养物40克。
根据本发明第一方面的养生蜂蜜膏,其中还包括果葡糖浆。在一个实施方案中,以每100克蜂蜜 计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下步骤的方法制备得到的:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4~6倍量的水煎煮提取1~3小时,滤取煎液保温 保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4~6倍量的水煎煮提取1~2小时,滤取煎液 保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至 含醇量达35~45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙 醇至含醇量达60~70%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使步骤(3)所得清液于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得 养生蜂蜜膏。已经出人意料的发现,在醇沉时加入果葡萄糖浆不但能够更加有效地除去杂质(步骤(3) 两次醇沉后去除的沉淀物量更多),而且能够最高程度地保持有效成分(绿原酸收获率高),这是现有技 术根本未曾教导的。
进一步的,本发明第二方面提供了一种制备具有清热润肺止咳化痰平喘和调节人体机能的养生蜂 蜜膏的方法,该方法包括如下步骤:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4~6倍量的水煎煮提取1~3小时,滤取煎液保温 保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4~6倍量的水煎煮提取1~2小时,滤取煎液 保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至 含醇量达35~45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙 醇至含醇量达60~70%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使步骤(3)所得清液于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得 养生蜂蜜膏。
根据本发明第二方面的方法,以每100克蜂蜜计,秋梨的量为50~150克,例如80~120克,例如 100克。
根据本发明第二方面的方法,以每100克蜂蜜计,罗汉果的量为20~100克,例如20~50克,例 如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,杏仁的量为10~50克,例如10~30克,例如20 克。
根据本发明第二方面的方法,以每100克蜂蜜计,白果的量为5~20克,例如5~10克,例如7.5 克。
根据本发明第二方面的方法,以每100克蜂蜜计,薄荷的量为5~20克,例如5~10克,例如7.5 克。
根据本发明第二方面的方法,以每100克蜂蜜计,金银花的量为20~100克,例如20~50克,例 如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,甘草的量为5~30克,例如5~20克,例如10 克。
根据本发明第二方面的方法,以每100克蜂蜜计,枇杷叶的量为20~100克,例如20~50克,例 如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,茶树花的量为50~250克,例如50~150克,例 如100克。
根据本发明第二方面的方法,以每100克蜂蜜计,雪莲培养物的量为20~100克,例如20~60克, 例如40克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、秋梨50~150克、罗汉果20~100克、 杏仁10~50克、白果5~20克、薄荷5~20克、金银花20~100克、甘草5~30克、枇杷叶20~100克、 茶树花50~250克、雪莲培养物20~100克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、秋梨80~120克、罗汉果20~50克、 杏仁10~30克、白果5~10克、薄荷5~10克、金银花20~50克、甘草5~20克、枇杷叶20~50克、茶 树花50~150克、雪莲培养物20~60克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、秋梨100克、罗汉果30克、杏仁20 克、白果7.5克、薄荷7.5克、金银花30克、甘草10克、枇杷叶30克、茶树花100克、雪莲培养物 40克。
根据本发明第二方面的方法,以每100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如 10克。
进一步的,本发明第三方面涉及养生蜂蜜膏在制备清热润肺止咳化痰平喘和调节人体机能的产品 中的用途。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜、秋梨、 罗汉果、杏仁、白果、薄荷、金银花、甘草、枇杷叶、茶树花、雪莲培养物。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,秋梨的量为50~150克, 例如80~120克,例如100克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,罗汉果的量为20~100克, 例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,杏仁的量为10~50克,例 如10~30克,例如20克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,白果的量为5~20克,例 如5~10克,例如7.5克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,薄荷的量为5~20克,例 如5~10克,例如7.5克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,金银花的量为20~100克, 例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,甘草的量为5~30克,例 如5~20克,例如10克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,枇杷叶的量为20~100克, 例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,茶树花的量为50~250克, 例如50~150克,例如100克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,雪莲培养物的量为20~100 克,例如20~60克,例如40克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、 秋梨50~150克、罗汉果20~100克、杏仁10~50克、白果5~20克、薄荷5~20克、金银花20~100克、 甘草5~30克、枇杷叶20~100克、茶树花50~250克、雪莲培养物20~100克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、 秋梨80~120克、罗汉果20~50克、杏仁10~30克、白果5~10克、薄荷5~10克、金银花20~50克、 甘草5~20克、枇杷叶20~50克、茶树花50~150克、雪莲培养物20~60克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、 秋梨100克、罗汉果30克、杏仁20克、白果7.5克、薄荷7.5克、金银花30克、甘草10克、枇杷 叶30克、茶树花100克、雪莲培养物40克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏中还包括果葡糖浆。在一个实施方案中,以每 100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下步骤的方法制备得到的:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4~6倍量的水煎煮提取1~3小时,滤取煎液保温 保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4~6倍量的水煎煮提取1~2小时,滤取煎液 保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至 含醇量达35~45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙 醇至含醇量达60~70%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使步骤(3)所得清液于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得 养生蜂蜜膏。
本发明的养生蜂蜜膏,通俗地讲,其是一种中药组合物。为此,根据本发明任一方面的任一实施 方案,其中所述中药组合物具有如本发明任一实施例中任一项所述的配方。
根据本发明任一方面的任一实施方案,其中所中药组合物具有如本发明任一实施例中任一项所述 的配方和制法。
在本发明上述制备方法的步骤中,虽然其描述的具体步骤在某些细节上或者语言描述上与下文具 体实施方式部分的制备例中所描述的步骤有所区别,然而,本领域技术人员根据本发明全文的详细公 开完全可以概括出以上所述方法步骤。
本发明的任一方面的任一实施方案,可以与其它实施方案进行组合,只要它们不会出现矛盾。此 外,在本发明任一方面的任一实施方案中,任一技术特征可以适用于其它实施方案中的该技术特征, 只要它们不会出现矛盾。下面对本发明作进一步的描述。
本发明所引述的所有文献,它们的全部内容通过引用并入本文,并且如果这些文献所表达的含义 与本发明不一致时,以本发明的表述为准。此外,本发明使用的各种术语和短语具有本领域技术人员 公知的一般含义,即便如此,本发明仍然希望在此对这些术语和短语作更详尽的说明和解释,提及的 术语和短语如有与公知含义不一致的,以本发明所表述的含义为准。
本发明的中药组合物采用蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花制成。
蜜蜂(Apis cerana Fabr或Apis mellifera L.)是从植物的花中采取含水量约为75%的花蜜或分泌物, 存入自己第二个胃中,在体内多种转化的作用下,经过15天左右反复酝酿各种维生素、矿物质和氨基 酸丰富到一定的数值时,同时把花蜜中的多糖转变成人体可直接吸收的单糖葡萄糖、果糖,水分含量 少于23%存贮到巢洞中,用蜂蜡密封。蜂蜜是糖的过饱和溶液,低温时会产生结晶,生成结晶的是葡 萄糖,不产生结晶的部分主要是果糖。蜂蜜的成分方面,蜂蜜因蜂种、蜜源、环境之不同,其化学组 成有很大差异。其主要成分是果糖和葡萄糖,两者含量合计约占70%,尚含少量蔗糖、麦芽糖、糊精、 树胶以及含氮化合物、有机酸、挥发油、色素、蜡、天然香料、植物残片(特别是花粉粒)、酵母、酶 类、无机盐等;蜂蜜一般只含微量维生素,其中有维生素A、维生素B1、维生素B2、维生素B6、维 生素C、维生素D、维生素K、尼克酸、泛酸、叶酸、生物素、胆碱等;在含氮化合物中有蛋白质、 胨、氨基酸等;尚含转化酶、过氧化氢酶、淀粉酶、氧化酶、还原酶等酶类,并含乙酰胆碱;灰分中主要含镁、钙、钾、钠、硫、磷以及微量元素铁、铜、锰、镍等;有机酸中含有柠檬酸、苹果酸、琥珀酸、甲酸、乙酸等;蜂蜜中含葡萄糖和果糖,约占65~80%;蔗糖极少,不超过8%;水分16~25%; 糊精和非糖物质、矿物质、有机酸等含量在5%左右;此外,还含有少量的酵素、芳香物质和维生素 等。蜜源植物品种不同,蜂蜜的成分也不一样。蜂蜜的药用功效有:蜂蜜能改进血液的成分,促进心 脑和血管功用,因而常常服用对于心血管患者很有好处;蜂蜜对肝脏有维护效果,能促进肝细胞再生, 对脂肪肝的形成有一定的抑制效果;食用蜂蜜能迅速弥补膂力,消除疲惫,增强对疾病的抵抗力;蜂 蜜还有灭菌的效果,常常食用蜂蜜,不仅对牙齿无影响,还能在口腔内起到灭菌消毒的效果;蜂蜜能 医治中度的肌肤损伤,特别是烫伤,将蜂蜜作为肌肤创伤敷料时,细菌无法成长;失眠的人在每天睡 觉前口服1汤匙蜂蜜(加入1杯温开水内),能够加快进入梦乡速度;蜂蜜还能够润肠通便(只要是天然 老练的真实蜂蜜都有润肠通便的效果)。蜂蜜的食用功效有:护肤美容,冬季皮肤干燥,可用少许蜂蜜调和水后涂于皮肤,可防止干裂,可用蜂蜜代替防裂膏;抗菌消炎、促进组织再生,优质蜂蜜在室温 下放置数年不会腐败,表明其防腐作用极强。实验证实,蜂蜜对链球菌、葡萄球菌、白喉等革兰阳性 菌有较强的抑制作用;促进消化,研究证明,蜂蜜对胃肠功能有调节作用,可使胃酸分泌正常。动物 实验证实,蜂蜜有增强肠蠕动的作用,可显著缩短排便时间;提高免疫力,蜂蜜中含有的多种酶和矿 物质,发生协同作用后,可以提高人体免疫力。实验研究证明,用蜂蜜饲喂小鼠,可以提高小鼠的免 疫功能;保护心血管,蜂蜜有扩张冠状动脉和营养心肌的作用,改善心肌功能,对血压有调节作用; 蜂蜜的功能主治:调补脾胃;缓急止痛;润肺止咳;润肠通便;润肤生肌;解毒。主脘腹虚痛;肺燥 咳嗽;肠燥便秘;目赤;口疮;溃疡不敛;风疹瘙痒;水火烫伤;手足皲裂。蜂蜜味甘;性平归脾; 胃;肺;大肠经。蜂蜜助减肥的原因:促进代谢,蜂蜜中所含酵素种类是所有食物种类最多的。这些 酵素可以帮助人体消化吸收,促进人体的新陈代谢;改善便秘,蜂蜜具有优良的杀菌与解毒效果,可 以帮助排出体内积聚的废物,如果是因为便秘症状而导致的肥胖,喝蜂蜜特别有效喔;平衡血糖降低空腹感,蜂蜜最主要的成分葡萄糖、果糖,都属于单糖,单糖在人体内不需经过消化作用,即可转化 为能量被吸收利用,让血糖值上升,所以只要喝一点蜂蜜,就可以降低你的空腹感,避免吃下过多食 物喔;不易积聚脂肪,蜂蜜本身不含脂肪,且相较于一般白糖,蜂蜜较轻易为人体吸收利用,只要食 用适量,蜂蜜比其他甜饮不会让你囤积脂肪。
秋梨又叫酸梨学名安梨,分布河北燕山一带和东北。果实约200克,扁圆形,成熟时比较酸,有 点淡淡的甜。耐储运,以前多为冬季在水果比较稀少时吃,经过几个月的储存,果实变软,酸味降低, 口感变好,但颜色较差好像变烂,因此北京,天津等地也称烂酸梨。酸梨本身酸度就较高因此,在农 村直接用来作醋,称酸梨醋,酸梨醋酸度较低,有甜味,拌凉菜很好吃。酸梨树寿命较长,在燕山一 带的老酸梨树达到一百年左右,若管理得当,单株产量可达五百公斤。梨含有蛋白质,脂肪,糖,粗 纤维,钙、磷、铁等矿物质,多种维生素等。具有降低血压、养阴清热的功效,患高血压、心脏病、 肝炎、肝硬化的病人,经常吃些梨大有益处;能促进食欲,帮助消化,并有利尿通便和解热作用,可 用于高热时补充水分和营养。煮熟的梨有助于肾脏排泄尿酸和预防痛风、风湿病和关节炎;而酸梨更 具有润燥消风、醒酒解毒等功效,在秋季气候干燥时,人们常感到皮肤搔痒、口鼻干燥,有时干咳少 痰,每天喝一碗梨汁可以缓解秋燥,有益健康。一般人群均可食用,咳嗽痰稠或无痰、咽喉发痒干疼者,慢性支气管炎、肺结核患者,高血压、心脏病、肝炎、肝硬化患者,饮酒后或宿醉未醒者尤其适 合。梨中含有丰富的B族维生素,能保护心脏,减轻疲劳,增强心肌活力,降低血压;梨所含的配糖 体及鞣酸等成分,能祛痰止咳,对咽喉有养护作用;梨有较多糖类物质和多种维生素,易被人体吸收, 增进食欲,对肝脏具有保护作用;梨性凉并能清热镇静,常食能使血压恢复正常,改善头晕目眩等症 状;食梨能防止动脉粥样硬化,抑制致癌物质亚硝胺的形成,从而防癌抗癌;梨中的果胶含量很高, 有助于消化、通利大便。
罗汉果,葫芦科多年生藤本植物的果实。别名拉汗果、假苦瓜、光果木鳖、金不换、罗汉表、裸 龟巴,被人们誉为“神仙果”,其叶心形,雌雄异株,夏季开花,秋天结果。主要产于广西,罗汉果是 桂林名贵的土特产,也是国家首批批准的药食两用材料之一,其主要功效是能止咳化痰。果实营养价 值很高,含丰富的维生素C(每100克鲜果中含400毫克~500毫克)以及糖甙、果糖、葡萄糖、蛋白质、 脂类等。罗汉果味甘性凉,归肺、大肠经,有润肺止咳、生津止渴的功效、适用于肺热或肺燥咳嗽、 百日咳及暑热伤津口渴等,此外还有润肠通便的功效。罗汉果含罗汉果甙(esgoside),较蔗糖甜300倍; 另含果糖、氨基酸、黄酮等。果中含非糖甜味的成分,主要是三萜甙类:罗汉果甙(mogroside)Ⅴ及Ⅳ[1-3], 甙Ⅴ的甜度是蔗糖(srcrose)的256-344倍,甙Ⅳ的甜度为蔗糖的126倍,不有甙Ⅳ则不呈甜味;次要的是D-甘露醇(D-mannitol),其甜度为蔗糖的0.55-0.65倍。还含大量葡萄糖(glucose),果糖(fructose)占 14%。含锰、铁、镍、硒、锡、碘、钼等26种无机元素、蛋白质、维生素C(vitaminC)等。种仁含油 脂41.07%,基中脂肪酸有:亚油酸(linoleic acid),油酸(oleic acid),棕榈酸(palmitic acid),硬脂酸(stearic acid),棕榈油酸(palmitoliec acid),肉豆蔻酸(myristic acid),月桂酸(lauric acid),癸酸(decanoic acid)。 罗汉果的果实和和叶均含有罗汉果三萜皂苷,还有大量的果糖、十多种人体必需氨基酸、脂肪酸、黄 酮类化合物、维生素C、微量元素等。罗汉果皂苷作为罗汉果甜味剂的主要成分,是一种具有甜味的三萜烯葡萄糖苷,其配糖苷元是三萜烯醇。葫芦素烷三萜类化合物是罗汉果中主要有效成分,它们有 共同的苷元结构。罗汉果中这类物质除少数外,均为甜味物质或微甜物质。其中罗汉果苷V主要的甜 味成分、它无毒、低热量、高甜度、热稳定性好,是作为天然甜味剂开发的物质之一。罗汉果干果中 含蛋白质7.1%-7.8%。在其水解物中,除色氨酸未被测定外,18种氨基酸齐全。在测定的氨基酸中, 含量较高的有谷氨酸(108.2-113.3mg/kg)、天冬氨酸(93.9-112.5mg/kg)、缬氨酸(52.5-55.5mg/kg)、丙氨 酸(49.9-66.8mg/kg)、亮氨酸(48.5-56.7mg/kg)。谷氨酸是人体中需要量最大的非必需氨基酸,是合成谷 胱甘肽的重要原料,可见,罗汉果具有较高的营养价值。罗汉果果实中含有24种无机元素,其中人体 必需的微量元素和广泛元素有16种,含量较高的元素有钾(12290mg/kg)、钙(667mg/kg)、镁(550mg/kg)。 罗汉果中含有的硒达到0.186mg/kg,是粮食的2倍-4倍,而元素硒在冠心病防治、抗衰老、抗癌方面 有较好的疗效。罗汉果为卫生部首批公布的药食两用名贵中药材,其所含罗汉果甜甙比蔗糖甜300倍, 不产生热量,是饮料、糖果行业的名贵原料,是蔗糖的最佳替代品。常饮罗汉果茶,可防多种疾病, 现代医学证明,罗汉果对支气管炎、高血压等疾病有显著疗效,还是起到防治冠心病、血管硬化、肥 胖症的作用。营养价值高,有清热解暑、化痰止咳、凉血舒骨、清肺润肠和生津止渴等功效;可治急 慢性气管炎、咽喉炎、支气管哮喘、百日咳、胃热、便秘、急性扁桃体炎等症,糖尿病患者亦宜服用。 中医药学认为,罗汉果甘、酸、性凉、有清热凉血、生津止咳、滑肠排毒、嫩肤益颜、润肺化痰等功 效,可用于益寿延年、驻颜悦色及治疗痰热咳嗽、咽喉肿痛、大便秘结、消渴烦躁诸症。药理作用: 止咳作用:D-甘露醇有止咳作用。又可用于脑水肿,能提高血液#渗透压,降低颅内压,脱水作用强 于尿素,且持续时间长。还可用于大面积烧伤和烫伤的水肿,防治急性肾功能衰竭病和降低眼球内压, 治疗急性青光眼以及代替糖作糖尿病患者的甜味食品或调味剂。对肠管作用:罗汉果健身茶(含罗汉果 77.5%,含茶叶15%,含7.5%罗汉果制剂)对小白鼠离体小肠自发活动无明显影响,但可加强家兔和狗 离体小肠自发活动。对乙酰胆碱或氯化钡引起的肠管强直性收缩均有拮抗作用,使肠管松弛而解痉; 对肾上腺素引起的肠管松弛也有拮抗作用,使肠管恢复自发性活动。表明罗汉果健身茶对肠管运动机 能有双向调节作用。其它作用:罗汉果健身茶对正常家兔胃生物电无影响,即不影响正常的消化道运 动机能。罗汉果健身茶给麻醉狗灌胃,血压和心电图均无明显影响。罗汉果有清热润肺的功效,但中 医文献中未记载罗汉果有养阴之功效。现代医学研究证实,罗汉果含一种比蔗糖甜300倍的甜味素, 但它不产生热量,所以是糖尿病、肥胖等不宜吃糖者的理想替代饮料。含丰富的维生素C,有抗衰老、 抗癌及益肤美容作用;有降血脂及减肥作用,可辅助治疗高脂血症,改善肥胖者的形象,是爱美女性 的必选水果。罗汉果可以做成罗汉果茶、罗汉糖果饮、罗汉果红枣茶、罗汉果鱼腥草、罗汉果益母草 汤、罗汉果粳米粥、罗汉雪梨饮、罗汉无花果茶、罗汉夏枯茶、罗汉五梅茶、罗汉果薄荷茶。还可作 为调味品用于炖品、清汤及制糕点、糖果、饼干。除干果出口外,制品尚有冲剂、糖浆、果精、止咳 露和浓缩果露等。
杏仁,Amygdalus Communis Vas,是蔷薇科杏的种子,分为甜杏仁和苦杏仁,主要含有蛋白质、 脂肪、糖、微量苦杏仁苷。脂肪的组成中主要是油酸和亚油酸。杏仁富含蛋白质、脂肪、糖类、胡萝 卜素、B族维生素、维生素C、维生素P以及钙、磷、铁等营养成分。其中胡萝卜素的含量在果品中 仅次于芒果,人们将杏仁称为抗癌之果。杏仁含有丰富的脂肪油,有降低胆固醇的作用,因此,杏仁 对防治心血管系统疾病有良好的作用;中医中药理论认为,杏仁具有生津止渴、润肺定喘的功效,常 用于肺燥喘咳等患者的保健与治疗。甜杏仁作为食品,可作扁桃仁的代替品。美国研究人员的一项最 新研究成果显示,胆固醇水平正常或稍高的人,可以用杏仁取代其膳食中的低营养密度食品,达到降 低血液胆固醇并保持心脏健康的目的。研究者认为,杏仁中所富含的多种营养素,比如维生素E,单 不饱和脂肪和膳食纤维共同作用能够有效降低心脏病的发病危险。样本中85位中老年志愿者(平均年 龄56岁)的总胆固醇水平降低了7.6%,低密度脂蛋白胆固醇水平下降了9%。也未造成体重的增加。 苦杏仁能止咳平喘,润肠通便,可治疗肺病、咳嗽等疾病。甜杏仁和日常吃的干果大杏仁偏于滋润, 有一定的补肺作用。杏仁还含有丰富的黄酮类和多酚类成分,这种成分不但能够降低人体内胆固醇的 含量,还能显著降低心脏病和很多慢性病的发病危险。杏仁还有美容功效,能促进皮肤微循环,使皮 肤红润光泽。杏仁还有抗肿瘤作用,杏仁抗肿瘤作用主要是由于苦杏仁中含有一种生物活性物质--苦 杏仁苷,可以进入血液专杀癌细胞,而对健康细胞没有作用,因此可以改善晚期癌症病人的症状,延 长病人生存期。同时,由于含有丰富的胡萝卜素,因此可以抗氧化,防止自由基侵袭细胞,具有预防 肿瘤的作用。杏仁具有镇咳、平喘作用,用于咳嗽气喘。本品主入肺经。味苦能降,且兼疏利开通之 性,降肺气之中兼有宣肺之功而达止咳平喘,为治咳喘之要药。随证配伍可用于多种咳喘病证。如风 寒咳喘,配伍麻黄、甘草,以散风寒,宣肺平喘,即三拗汤。风热咳嗽,配伍桑叶,菊花,以散风热, 宣肺止咳,如桑菊饮。燥热咳嗽,配伍桑叶、贝母、沙参,以清肺润燥止咳,如桑杏汤。肺热咳喘,配伍石膏等以清肺泄热,宣肺平喘,如麻杏石甘汤。杏仁具有对消化系统的作用,杏仁味苦下气,且 富含脂肪油。脂肪油能提高肠内容物对黏膜的润滑作用,故杏仁有润肠通便之功能。杏仁具有抗炎、 镇痛作用,苦杏仁苷分解产生的苯甲醛静安息香缩合酶作用生成安息香。安息香具有镇痛作用,因此 国内有人用苦杏仁治疗晚期肝癌可解除病人的痛苦,有的甚至不需服用止痛药。杏仁具有抗肿瘤作用, 有关杏仁抗肿瘤机理的研究主要有以下几方面:①一部分学者认为癌细胞中含有大量β-葡萄糖苷酶, 该酶能水解苦杏仁苷产生氢氰酸(HCN)、苯甲醛和葡萄糖。由于癌细胞缺少硫腈生成酶,该酶具有对 HCN的解毒作用,使HCN变成无毒的硫腈化物,而正常细胞缺少β-葡萄糖苷酶而含有大量的硫腈生 成酶。依据该理论,苦杏仁苷应该能够选择性杀死癌细胞,而对正常细胞几乎无害。②苦杏仁苷能帮 助体内胰蛋白酶消化癌细胞的透明样黏蛋白膜,使体内白细胞更易接近癌细胞,并吞噬癌细胞。③有 人发现苦杏仁苷类似NaSCN和NaOCN能够影响胸腺嘧啶核苷进入肝瘤细胞DNA和肿瘤细胞对磷酸 盐及氨基酸的吸收。杏仁具有降血糖作用,苦杏仁苷具有防治因抗肿瘤药阿脲引起的糖尿病的作用。 采用阿脲诱发小鼠高血糖法证明,预先腹腔注射3g/kg苦杏仁苷48h后测血糖,结果表明苦杏仁苷可 特异性地抑制阿脲所致的血糖升高,作用强度与血液中苦杏仁苷的浓度有关。杏仁具有降血脂作用, 临床报道,大杏仁可以明显降低高血脂患者的血脂水平,Spiller(1990年)认为杏仁中的单不饱和脂肪 酸有助于降低患者轻度升高的血脂,且无需严格限制饮食。杏仁具有美容作用,根据肺合皮毛理论, 在临床上对某些皮肤疾病可从宣肺法论治,配伍食用杏仁,常获捷效。现代研究证明,苦杏仁中所含 的脂肪油可使皮肤角质层软化,从而达到美容的效果。杏仁具有肠燥便秘作用,本品含有油脂而质润, 味苦而下气,故能润肠通便。常配伍柏子仁、郁李仁等同用,如《世医得效方》之五仁丸。杏仁的其 他作用,苦杏仁苷具有抗突变作用,能减少由安乃近、灭滴灵、丝裂霉素C等引起的微核多染性红细 胞的数量。苦杏仁甙水解产物苯甲醛在体外以及在健康者或溃疡者体内,均能抑制胃蛋白酶的消化功 能,提示其有抗溃疡作用。杏仁水溶性部分的胃蛋白酶水解产物对经过四氯化碳处理过的大鼠给药, 有抑制SGOT、SGPT水平和羟脯氨酸含量的升高,并抑制优球蛋白溶解时间的延长。杏仁的胃蛋白 酶水解产物对乙酸引起的小鼠扭体和棉球引起的大鼠肉芽肿炎症有抑制作用,但并不抑制角叉菜胶引 起的大鼠脚爪急性肿胀及佐剂所致的大鼠关节炎的一期和二期损伤的发展。对佐剂引起的关节炎鼠, 杏仁的胃蛋白酶水解产物给药2个月能延长优球蛋白溶解时间,并抑制腹动脉结缔组织的增殖。苦杏 仁油还有驱虫、杀菌作用,体外试验对人蛔虫、蚯蚓有杀死作用,并对伤寒、副伤寒杆菌有抗菌作用。杏仁还具有抗蛲虫和滴虫感染,治疗再生障碍性贫血作用。实验表明:苦杏仁煎剂对正常家兔有促进 总磷合成的功能,治疗油酸型成年兔呼吸窘迫综合征取得了病理改善的结果。提示苦杏仁可促进肺表 面活性物质的合成,可试用于临床治疗成人呼吸窘迫总综合征。
白果(学名:Ginkgo biloba),又名鸭脚子、灵眼、佛指柑,银杏、公孙树子,是银杏的种仁,中 药白果为银杏科植物银杏的干燥成熟种子。椭圆形,长1.5~2.5cm,宽1~2cm,厚约1cm。表面 黄白色或淡黄棕色,平滑坚硬,一端稍尖,另端钝,边缘有2~3条棱线,中种皮(壳)质硬,内种皮膜 质。一端淡棕色,另端金黄色。种仁粉性,中间具小芯,味甘、微苦。白果主要分为药用白果和食用 白果两种,药用白果略带涩味,食用白果口感清爽。白果果仁除含有淀粉、蛋白质、脂肪、糖类之外, 还含有维生素C、核黄素、胡萝卜素、钙、磷、铁、钾、镁等微量元素以及银杏酸、白果酚、五碳多 糖,脂固醇等成分,营养丰富。中医认为,白果能敛肺气、定痰喘、止带浊、止泻泄、解毒、缩小便, 主治哮喘痰嗽、带下白浊、小便频数、遗尿等。白果具有通畅血管、保护肝脏、改善大脑功能、润皮 肤、抗衰老、治疗老年痴呆症和脑供血不足等功效。白果含有多种营养元素,除蛋白质、脂肪、糖类 之外,还含有维生素C、维生素B2、胡萝卜素、钙、磷、铁、钾、镁等微量元素,以及银杏酸、白果 酚、多糖等成分。白果可治疗座疮,其中所含的苦内脂等对脑血栓、高血压、冠心病等有特殊的疗效。 适用分量每次10克左右。一般人均可食用,特别适合尿频者,体虚白带的女生。有实邪者忌服。生食 或超食过量可致中毒,小儿误服中毒尤为常见。白果可以滋阴养颜抗衰老,使人肌肤、面部红润。白果的临床疗效方面,1.治哮喘,痰嗽,白带,白浊,遗精,淋病,小便频数。①.敛肺平喘,减少痰 量:适用于咳喘气逆,痰多之症,无论偏寒,偏热均可。②.收涩止带,除湿:用治白浊带下。无论下 元虚衰,白带清稀,或湿热下注、带下黄浊者,随症配伍,均可使用。③.祛痰定喘:用于治疗喘咳痰 多,能消痰定喘。④.收敛除湿:可治疗赤白带下,小便白浊,小便频数、遗尿。2.治疗肺结核用法: 在中秋节前夕,将半青带黄的银杏(选取外表丝毫无损的大颗粒)摘下,不用水洗,亦不去柄,随即浸 入生菜油内,浸满100天后即可使用。每日早、中、晚各服1粒(小儿酌减),饭前服,视病情连服1~ 3个月。3.抑菌杀菌:白果中含有的白果酸、白果酚,经实验证明有抑菌和杀菌作用,可用于治疗呼 吸道感染性疾病。白果水浸剂对各种真菌有不同程度的抑制作用,可止痒疗癣。4.降低血清胆固醇, 扩张冠状动脉:银杏叶中含有莽草酸、白果双黄酮、异白果双黄酮、甾醇等,用于治疗高血压及冠心 病、心绞痛、脑血管痉挛、血清胆固醇过高等病症都有一定效果。5、新鲜白果中提出的白果酚甲,对 离体兔肠有麻痹作用,使离体子宫收缩,对蛙心无影响。白果种仁含无氮的中性成分,给小鼠皮下注射6mg/13g,半小时后可致惊厥,延髓麻痹,随即呼吸、心跳停止而死。旧说其中含氢氰酸,能镇咳 并致中毒,但未能检得氢氰酸的存在;也有说不能证明白果中含有对小鼠引起惊厥的物质。白果肉尚 有收敛作用。
薄荷,Mentha haplocalyx Briq.,土名叫“银丹草”,为唇形科植物,即同属其他干燥全草。多生于 山野湿地河旁,根茎横生地下,多生于2100米海拔高度,但也可在3500米海拔上生长,是一种有特 种经济价值的芳香作物。全株青气芳香。叶对生,花小淡紫色,唇形,花后结暗紫棕色的小粒果。薄 荷是中华常用中药之一。它是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿 痛等症。外用可治神经痛、皮肤瘙痒、皮疹和湿疹等。平常以薄荷代茶,清心明目。光棚温室采摘的 薄荷又是春节餐桌上的鲜菜。清爽可口。在中国,薄荷主要以江苏、安徽两省产量最大。薄荷栽种方 式有根茎栽植、分株栽植和扦插繁殖三种。薄荷广泛分布于北半球的温带地区,中国各地均有分布。 中国各地多有栽培,其中江苏、安徽为传统地道产区,但栽培面积日益减少。热带亚洲,俄罗斯远东 地区,朝鲜,日本及北美洲(南达墨西哥)也有。薄荷是中国常用中药,幼嫩茎尖可作菜食,全草又可 入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、 疥、癣、漆疮亦有效。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。大量食用薄荷可导致失眠,但小剂量 食用却有助于睡眠。
金银花,正名为忍冬(学名:Lonicera japonica Thunb.)。“金银花”一名出自《本草纲目》,由于忍 冬花初开为白色,后转为黄色,因此得名金银花。药材金银花为忍冬科忍冬属植物忍冬及同属植物干 燥花蕾或带初开的花。《神农本草经》载:“金银花性寒味甘,具有清热解毒、凉血化淤之功效,主治 外感风热、瘟病初起、疮疡疔毒、红肿热痛、便脓血”等。《本草纲目》中详细论述了金银花具有“久服 轻身、延年益寿”的功效。二十世纪八十年代,国家卫生部对金银花先后进行了化学分析,结果表明: 金银花含有多种人体必须的微量元素和化学成分,同时含有多种对人体有利的活性酶物质,具有抗衰 老,防癌变,轻身健体的良好功效。金银花最早栽培记载见于宋代《苏沈内翰良方》,其中称:“可移 根庭栏间,以备急。”许多地方县志也有记载,如清光绪二十二年《费县志》称:“花有黄白故名金银 花,从前间有之,不过采以代茶,至嘉庆初,商旅贩往他处,……不数年山角水湄栽植几遍。”由此可知,金银花有着悠久的栽培历史。1984年国家中医药管理局将其确定为35种名贵中药材之一,后来 又被确定为药食兼用品种。金银花药用历史悠久,早在3000年前,我们祖先就开始用它防治疾病,在 《名医别录》中被列为上品。金银花自古以来就以它的药用价值广泛而著名。其功效主要是清热解毒, 主治温病发热、热毒血痢、痈疽疔毒等。现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性 成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另 外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其 临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40 余种病症。金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满 下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、 肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁 桃体炎等病症均有一定疗效。金银花藤煲水后对小孩湿疹等皮肤瘙痒有一定治疗作用,对畜禽的多种 至病的病菌、病毒有抑制作用,在动物饲养过程中若能添加一定剂量的金银花藤叶(忍冬藤)粉或煲水, 对预防和治疗动物的温病发热、风热感冒、咽喉炎症、肺炎、痢疾、肿溃疡、丹毒、蜂窝组织炎等症 均有相当好的作用。用连翘,板蓝根煎金银花汤可以治疗腮腺炎;金银花茶可以祛暑明目;连翘金银 花凉汤可治疗外感发热咳嗽。同时将金银花、菊花、桔梗和甘草加水煮沸10分钟,侯凉,当饮料饮用, 可治疗咽喉炎和扁桃体炎。已生产的金银花制剂有“银翘解毒片”、“银黄片”、“银黄注射液”等。“金银 花露”是金银花用蒸馏法提取的芳香性挥发油及水溶性溜出物,为清火解毒的良品,可治小儿胎毒、疮 疖、发热口渴等症;暑季用以代茶,能治温热痧痘、血痢等。茎藤称“忍冬藤”,也供药用。金银花的 有效成份为绿原酸和异绿原酸。这是植物代谢过程中产生的次生物质,其含量的高低不仅取决于植物 的种类,而且可能在很大程度上受气候、土壤等生态、地理条件以及物候期的影响。金银花茶有独特 的减肥功能,还能抑制与杀灭咽喉部的病原菌,对老人和儿童有抗感染功效。经常服用金银花浸泡或 煎剂有利于风火目赤、咽喉肿痛、肥胖症、肝热症和肝热型高血压的治疗与康复。金银花在临床上的 应用如下:温病初期:常与;连翘、薄荷、淡豆鼓等同用,具有清热解毒、疏风解表作用,可用以温 病初期,发热微恶寒风寒,口微渴,如银翘散。痈疽疔毒:常与蒲公英、紫地丁、野菊花等同用,能 增强清热解毒作用,可用以痈疽疔毒,红肿疼痛,如五味消毒饮。温病中期:常与黄芩、栀子、石膏、 竹茹、芦根等同用,具有清热解毒、透邪外出、和胃止呕作用,可用以邪热壅阻,胃气不和,发热烦 躁,胸膈痞闷,口渴干呕,舌红苔燥,脉象滑数。赤痢:常与黄连、赤芍、木香、马齿苋等同用,具 有清热理肠、化滞和血作用,可用以湿热中阻、损伤肠络脂膜,下痢脓血,血多于脓,腹痛,里急后 重。疫痢:常与生地黄、赤芍、丹皮、黄连、黄柏、白头翁等同用,具有清热解毒、凉血止痢作用, 可用以疫毒侵袭肠胃,与气血搏结,痢下鲜紫脓血,壮热口渴,烦躁不安,甚至神昏谵语。金银花的 药毒理学方面,金银花水浸液灌胃,对家兔、犬等无明显毒性反应,对呼吸、血压、尿量均无影响。 小鼠皮下注射本品浸膏的LD50为53g/kg。绿原酸具有致敏原作用,可引起变态反应,但口服无此反应,因绿原酸可为小肠分泌物转化为无致敏活性的物质。溶血试验结果表明:蒸晒品0.1~0.5mL均在 3小时内无溶血现象;生晒品0.1~0.5mL在加药后立即出现溶血现象;贵州山银花0.1~0.5mL均在3 小时内无溶血现象;河南蜜银花pH6.0时0.1~0.3mL无溶血现象;山东济银花:0.1~0.5mL均在3 小时无溶血现象。5种材料的LD50顺序为:蜜银花<济银花<蒸晒品<贵州商品,灰毡毛忍冬蒸晒品无 溶血性,而生晒的有溶血性,故作注射液原料,必须采用蒸晒品。具体地说,1、抗病原微生物作用: 体外实验表明,花和藤对多种致病菌如金黄色葡萄球菌、溶血性链球菌、大肠杆菌、痢疾杆菌、霍乱 弧菌、伤寒杆菌、副伤寒杆菌等均有一定抑制作用,对肺炎球菌、脑膜炎双球菌、绿脓杆菌、结核杆 菌亦有效。水浸剂比煎剂作用强,叶煎剂比花煎剂作用强。若和连翘合用,抗菌范围还可互补;与青 霉素合用,能加强青霉素对耐药金黄色葡萄球菌的抗菌作用,这可能是在抑制细菌体内蛋白质合成上 有协同的作用。2、抗炎和解热作用:腹腔注射金银花提取液0.25g/kg,能抑制大鼠角叉菜胶性脚肿。 另有报道金银花注射液30~40g/kg能减轻蛋清性脚肿程度。腹腔注射金银花提取液8g/kg,2次/天, 连续6天,对大鼠巴豆油性肉芽囊,也有明显抗渗出和抗增生的作用。早期报道金银花具有明显的解 热作用,但用霍乱菌苗、马铃薯杆菌、枯草浸液等给家兔耳静脉注射,致热,未证实金银花煎剂5g/kg 灌胃有退热作用,认为这可能和使用的金银花制剂、剂量或家兔的耐受性不同有关。3、加强免疫机能 作用:金银花煎剂稀释至1:1280的浓度,仍能促进白细胞的吞噬功能。小鼠腹腔注射金银花注射液, 也有明显促进炎性细胞吞噬功能的作用。4、中枢兴奋作用:经电休克、转笼等多种实验方法证明口服 绿原酸后,可引起大鼠、小鼠等动物中枢神经系统兴奋,其作用强度为咖啡因的1/6,二者合用无相 加及增强作用。5、降血脂作用:大鼠灌胃金银花2.5g/kg能减少肠内胆固醇吸收,降低血浆中胆固醇 含量。体外实验也发现金银花可和胆固醇相结合,但四妙勇安汤(金银花、玄参、当归、甘草)治疗家 兔实验性动脉粥样硬化。未观察到有降血脂和主动脉壁胆固醇含量的作用。6、抗内毒素:用鲎试验法 测定内毒素含量,300%金银花(忍冬)注射液以1:2~1:64稀释,体外试验无论用凹片法或试管法,均 明显降低试液中的内毒素含量,其中1:2~1:8的稀释管与阴性对照管一样呈液态,阳性对照呈凝胶状。 金银花(忍冬)蒸馏液6g/kg静脉注射,对绿脓杆菌内毒互2.8mg/kg静脉注射引起的兔体温下降及白细 胞数下降有对抗作用,金银花(忍冬)蒸馏液7.5g/kg或注射液2.5g/kg腹腔注射,对绿脓杆菌内毒素 65mg/kg腹腔注射的小鼠有保护作用,减少小鼠死亡率。7、其它作用:曾有体外筛选实验报告金银花 的水及酒浸液对肉瘤180及艾氏腹水癌有明显的细胞毒作用。金银花提取物口服对大鼠实验性胃溃疡 有轻度预防效果。口服大剂量绿原酸能增加胃肠蠕动,促进胃液及胆汁分泌。绿原酸及其分解产物对 大鼠离体子宫有兴奋作用。此外,绿原酸还能轻微增强肾上腺素及其去甲肾上腺素对猫和大鼠的升压 作用,但对猫的瞬膜反应无影响。
甘草,Glycyrrhiza uralensis Fisch,别名:国老、甜草、乌拉尔甘草、甜根子。豆科、甘草属多年 生草本,根与根状茎粗壮,是一种补益中草药。对人体很好的一种药,药用部位是根及根茎,药材性 状根呈圆柱形,长25~100厘米,直径0.6~3.5厘米。外皮松紧不一,表面红棕色或灰棕色。根茎呈 圆柱形,表面有芽痕,断面中部有髓。气微,味甜而特殊。功能主治清热解毒、祛痰止咳、脘腹等。 喜阴暗潮湿,日照长气温低的干燥气候。甘草多生长在干旱、半干旱的荒漠草原、沙漠边缘和黄土丘 陵地带。根和根状茎供药用。甘草的功效:1.用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠 乏力等。前者,常与桂枝配伍,如桂枝甘草汤、炙甘草汤。后者,常与党参、白术等同用,如四君子 汤、理中丸等。2.用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与 金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。咽喉肿痛,常与桔梗同用,如桔梗汤。若 农药、食物中毒,常配绿豆或与防风水煎服。3.用于气喘咳嗽。可单用,亦可配伍其他药物应用。如 治湿痰咳嗽的二陈汤;治寒痰咳喘的苓甘五味姜辛汤;治燥痰咳嗽的桑杏汤;治热毒而致肺痈咳唾腥 臭脓痰的桔梗汤;治咳唾涎沫的甘草干姜汤等。另风热咳嗽、风寒咳嗽、热痰咳嗽亦常配伍应用。4.用 于胃痛、腹痛及腓肠肌挛急疼痛等,常与芍药同用,能显著增强治挛急疼痛的疗效,如芍药甘草汤。5.用 于调和某些药物的烈性。如调味承气汤用本品缓和大黄、芒硝的泻下作用及其对胃肠道的刺激。另外, 在许多处方中也常用本品调和诸药。7甘草有类似肾上腺皮质激素样作用。对组胺引起的胃酸分泌过 多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。8.甘草黄酮、甘草浸膏及甘草次酸均有明显的 镇咳作用;祛痰作用也较显著,其作用强度为甘草酸>甘草黄酮>甘草浸膏。9.甘草还有抗炎,抗过敏 作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。 10.甘草常用来治疗随更年期而来的症状.因为甘草里含有甘草素,是一种类似激素的化合物,它有助 于平衡女性体内的激素含量。11.甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。甘草含有多种化 学成分,主要成分有甘草酸、甘草甙等。甘草的化学组成极为复杂,目前为止从甘草中分离出的化合 物有甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草 西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物,但这些成分和数量通常会随 甘草的种类、种植区域、采收时间等因素的不同而异。大量的研究表明,甘草甜素和黄酮类物质是甘 草中最重要的生理活性物质,主要存在于甘草根表皮以内的部分。
枇杷叶,Eriobotrya japonica Thunb.,为蔷薇科植物枇杷的叶子。又名巴叶、芦桔叶(《中药材手 册》)。原植物枇杷又名:卢橘(广东)。有清肺止咳,和胃利尿,止渴的功效。有治疗肺热痰嗽,咳血, 衄血,胃热呕哕作用。中国大部分地区均有栽培。分布于中南及陕西、甘肃、江苏、安徽、浙江、江 西、福建、台湾、四川、贵州、云南等地。全年均可采收,晒干,刷去毛,切丝生用或蜜炙用。枇杷 叶味苦,性微寒,主入肺、胃经,善降肺胃气逆而止咳、止呕,为痰热咳嗽及胃热呕逆所常用。枇杷 叶具有如下作用:1、镇咳、祛痰、平喘作用本品所含苦杏仁甙在体内水解产生的氢氰酸有止咳作用.水 煎剂或乙酸乙酯提取物有祛痰和平喘作用.其叶所含之挥发油有轻度祛痰作用.亦有报告指出,枇杷 叶止咳作用强,祛痰作用较差。2、抗菌作用实验表明:本品水煎剂或乙酸乙酯提取物对白色或金黄色 葡萄球菌、肺炎双球菌、福氏痢疾杆菌均有抗菌作用.但有人认为,枇杷叶无抗菌作用,并能刺激金 黄色葡萄球菌的生长。3、其他作用,有报告指出,枇杷叶乙醇冷浸提取物对大鼠角叉菜胶所致足肿胀 局部用药有抗炎作用,温浸提取物局部用药或灌胃给药、冷浸提取物灌胃给药均无抗炎作用。枇杷叶 含挥发油,主要成分为橙花叔醇(Nerolidol)和金合欢醇(Farnesol).尚有α和β蒎烯、莰烯、月桂烯、 对聚伞花素、芳樟醇、α-衣兰烯、α和β金合欢烯、樟脑、橙花醇、牻牛儿醇、α-毕澄茄醇、榄香 醇、顺-β,γ-己烯醇和芳樟醇氧化物.亦含苦杏仁甙(Amygdalin)、熊果酸、齐墩果酸、酒石酸、柠 檬酸、苹果酸、鞣质、维生素B和维生素C等.还含山梨糖醇(Sorbitol).新鲜叶含挥发油0.045%-0.108%, 其主要成分为橙花叔醇(nerolidol)和金合欢醇(farnesol)。叶中含苦杏仁甙(amygdalin),酒石酸(tartaricacid),枸橼酸(citric acid),苹果酸(malic acid),齐墩果酸(oleanolic acid),熊果酸(ursolic acid),2a-羟基 熊果酸(2a-hydroxyursolic acid),6a,19a-二羟基熊果酸(6a,19a-dihydroxyursolic acid),马斯里酸(maslinic acid),枇杷呋喃(eriobofuran),枇杷佛林(loguatifolin)A,金丝桃甙(hyperoside)以及4个倍半萜甙:橙 花叔醇-3-O-a-L-吡喃鼠李糖基-(1→2)-β-D-吡喃葡萄糖甙 (nerolidol-3-O-a-L-rhamnopyranosyl-(l→2)-β-D-glucopyranoside),橙花叔醇-3-O-a-L-吡喃鼠李糖基 -(1→4)-a-L-吡喃鼠李糖基-(1→2)-β-D-吡喃葡萄糖甙 (nerolidol-3-O-a-L-rhamnopyranosyl-(1-4)-a-L-rhamnopyranosyl-(l→2)-β-D-glucopyranoside),橙花叔醇 -3-O-a-L-吡喃鼠李糖基-(1→4)-a-L-吡喃鼠李糖基-(1→6)-β-D-吡喃葡萄糖甙 (nerolidol-3-O-a-L-rhamnopyranosyl-(1→4)-a-L-rhamnopyranosyl-(l→6)-β-D-glucopyranoside),橙花叔醇-3-O-(a-L-吡喃鼠李糖基(1→4)-a-L-吡喃鼠李糖基(1→2)-[-a-L-吡喃鼠李糖基(1-6)]-β-D-吡喃葡萄糖 甙)。
茶树花内含成分具有解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力等功效,其蛋白质、 茶多糖、茶多酚、活性抗氧化物质超出茶叶中同类物质含量,农药残留和重金属含量低于欧盟标准。 茶树花是一种优质蛋白营养源,可与世界公认的抗氧化植物迷迭香媲美。出身于茶叶世家的徐纪英女 士,首次发现茶树花营养成分丰富,活性成份极高,具有很高的开发利用价值。茶树花与茶叶一样, 也有很多对人体有益的养生功效。因为茶树花生长期较长,所以含有多种对人体有益的物质,特别是 抗氧化物质含量很高,其抗氧化能力也是比较强的。同时还具有解毒、降脂、降糖、抗衰老、抗癌、 抑癌、滋补、壮体、养颜美容等功效。茶树花的资源状况:1.据2009年国土资源部统计,全国茶园面 积已达2800万亩,分布于19个省1000多个县。成龄茶园每亩可采鲜花200千克以上,全国可采集鲜 花500万吨左右,可制成干花原料30多万吨。茶树花是一种无需重新栽培、储量丰富、年年可再生的 天然资源。2.中华人民共和国国家卫生和计划生育委员会2013批准茶树花等7种新资源食品。
雪莲培养物,Saussurea involucrate,是在无菌条件下,将雪莲离体的植物器官、组织、细胞、胚 胎或原生质体培养在人工配制的培养基上,在人工控制的条件下进行培养,使其组织或细胞增值进而 按照需要进行培养的技术;或使其脱分化产生愈伤组织,并再逐步分化出器官并长成完整的植株而生 产的培养物。雪莲培养物采用植物细胞培养技术获得,该技术是近些年来国际上发展起来的一门高新 技术,也是当今国际通用的一项成熟技术。它就是在无菌条件下,将离体的植物器官、组织、细胞、 胚胎或原生质体培养在人工配制的培养基上,在人工控制的条件下进行培养,使其组织或细胞增值进 而按照需要进行培养的技术;或使其脱分化产生愈伤组织,并再逐步分化出器官并长成完整的植株的 方法。雪莲的特点有:1、甄选出最佳的野生天山雪莲种子,保证了雪莲体细胞的基因优势;2、严格控制培养条件,使雪莲细胞能够获得最好的生存环境和充足的营养素,保证了植物体细胞的超高品质; 3、经过上千次的筛选、培养、再筛选,获得的雪莲体细胞药用成份较野生雪莲更适合人体吸收,大大 提高了生物利用度;4、现代高科技生物工程、严格的质量控制体系,保证了培养的雪莲体细胞不会出 现植株退化现象。5、在自然资源日益枯竭的今天,它从根本上解决了资源的可持续供应问题,填补了 国内空白。雪莲(Saussurea involucrate(Kar.et Kir.)Sch.Bip)是新疆特有的名贵中草药。维吾尔医认为, 雪莲补肾活血,强筋骨,营养神经,调节异常体液。中医认为,雪莲温肾助阳,祛风胜湿,通经活血。 雪莲的独特功效越来越受到重视,临床主要用于素体阳虚、血瘀阻络之风寒湿痹痛、小腹疼痛、月经 不调等病证的预防和治疗,亦在抗早孕方面。为保护此名贵的物种,采用具有我国独立知识产权的植 物细胞工程技术制备雪莲代用品获得成功。经系统研究表明,雪莲培养物不仅含有与天然雪莲相近的 活性成分,且亦具有与之相当的多方面的药理活性。其主要药理作用镇痛、抗炎、抗风湿;抑制血小 板聚集、降血脂、改善血液循环;对免疫系统具有调节作用;同时还有抗氧化、抗辐射、和抗疲劳等 多方面的药效学作用。
本发明的养生蜂蜜膏采用蜂蜜、秋梨、罗汉果、杏仁、白果、薄荷、金银花、甘草、枇杷叶、茶 树花、雪莲培养物制成。呈现这些药材的组合生物学功效,特别是具有显著的清热润肺止咳化痰平喘 和调节人体机能的功效。例如,针对长期表现为咳嗽、痰多、气喘的57岁至64岁受试者36人,每人 每天给予本发明实施例1所得养生蜂蜜膏25g,分早晚两次服用,1个月后,全部受试者的咳嗽、痰多、 气喘的状态均完全消失。这表明,本发明的养生蜂蜜膏具有优异的调节人体机能的效果。
另外,基于本发明养生蜂蜜膏中的各种药材的生理学性能,完全可以预期本发明养生蜂蜜膏能够 呈现这些药材各自或组合产生的生物学效应,例如能够产生秋梨典型的祛痰止咳效果;罗汉果典型的 清热润肺止咳、生津止渴效果;杏仁典型的镇咳、平喘作用、咳嗽气喘效果;白果典型的敛肺平喘、 祛痰定喘效果;薄荷典型的辛凉性发汗解热药效果;金银花典型的清热解毒、凉血化淤效果;甘草典 型的清热解毒、祛痰止咳、脘腹效果;枇杷叶典型的清肺止咳、和胃利尿、止渴效果;茶树花典型的 解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力等功效效果;雪莲培养物典型的镇痛、抗炎、 抗风湿;抑制血小板聚集、降血脂、改善血液循环、对免疫系统的调节作用、抗氧化、抗辐射、和抗 疲劳等多方面的药效学作用。特别是例如完全可以预期本发明养生蜂蜜膏具有优异的综合生物学功能 特别是治疗、预防和保健功能,特别是具有解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力、镇痛、抗炎、抗风湿、抑制血小板聚集、降血脂、改善血液循环、调节免疫系统、抗氧化、抗辐射、 抗疲劳等多方面的药效学作用。因此,本发明第三方面的用途还包括上述这些治疗/预防效果所涉及的 用途。
具体实施方式
通过下面的实施例可以对本发明进行进一步的描述,然而,本发明的范围并不限于下述实施例。 本领域的专业人员能够理解,在不背离本发明的精神和范围的前提下,可以对本发明进行各种变化和 修饰。本发明对试验中所使用到的材料以及试验方法进行一般性和/或具体的描述。虽然为实现本发明 目的所使用的许多材料和操作方法是本领域公知的,但是本发明仍然在此作尽可能详细描述。
实施例1:制备养生蜂蜜膏
配方:蜂蜜100克、秋梨100克、罗汉果30克、杏仁20克、白果7.5克、薄荷7.5克、金银花 30克、甘草10克、枇杷叶30克、茶树花100克、雪莲培养物40克、果葡糖浆10克。
制法:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用5倍量的水煎煮提取2小时,滤取煎液保温保存, 滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加5倍量的水煎煮提取1.5小时,滤取煎液保 温保存;滤渣加3倍量的水煎煮提取0.75小时,滤取煎液保温保存;
(3)将合并的三次煎液于75℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含 醇量达40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含 醇量达65%,搅拌均匀,静置2.5小时,过滤取清液;
(4)使步骤(3)所得清液于55℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生 蜂蜜膏。
实施例2:制备养生蜂蜜膏
配方:蜂蜜100克、秋梨150克、罗汉果20克、杏仁50克、白果5克、薄荷20克、金银花20 克、甘草30克、枇杷叶20克、茶树花250克、雪莲培养物20克、果葡糖浆25克。
制法:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用6倍量的水煎煮提取1小时,滤取煎液保温保存, 滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4倍量的水煎煮提取2小时,滤取煎液保温 保存;滤渣加2倍量的水煎煮提取1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含 醇量达45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含 醇量达60%,搅拌均匀,静置3小时,过滤取清液;
(4)使步骤(3)所得清液于50℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生 蜂蜜膏。
实施例3:制备养生蜂蜜膏
配方:蜂蜜100克、秋梨50克、罗汉果100克、杏仁10克、白果20克、薄荷5克、金银花100 克、甘草5克、枇杷叶100克、茶树花50克、雪莲培养物100克、果葡糖浆5克。
制法:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4倍量的水煎煮提取3小时,滤取煎液保温保存, 滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加6倍量的水煎煮提取1小时,滤取煎液保温 保存;滤渣加4倍量的水煎煮提取0.5小时,滤取煎液保温保存;
(3)将合并的三次煎液于80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含 醇量达35%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含 醇量达70%,搅拌均匀,静置2小时,过滤取清液;
(4)使步骤(3)所得清液于60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生 蜂蜜膏。
实施例4:制备养生蜂蜜膏
配方:蜂蜜100克、秋梨120克、罗汉果20克、杏仁30克、白果5克、薄荷10克、金银花20 克、甘草20克、枇杷叶20克、茶树花150克、雪莲培养物20克、果葡糖浆20克。
制法:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4.5倍量的水煎煮提取1.5小时,滤取煎液保温 保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加5.5倍量的水煎煮提取1.8小时,滤取煎液 保温保存;滤渣加2.5倍量的水煎煮提取0.9小时,滤取煎液保温保存;
(3)将合并的三次煎液于78℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含 醇量达43%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含 醇量达62%,搅拌均匀,静置2.8小时,过滤取清液;
(4)使步骤(3)所得清液于53℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生 蜂蜜膏。
实施例5:制备养生蜂蜜膏
配方:蜂蜜100克、秋梨80克、罗汉果50克、杏仁10克、白果10克、薄荷5克、金银花50克、甘草5克、枇杷叶50克、茶树花50克、雪莲培养物60克、果葡糖浆5克。
制法:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用5.5倍量的水煎煮提取2.5小时,滤取煎液保温 保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4.5倍量的水煎煮提取1.2小时,滤取煎液 保温保存;滤渣加3.5倍量的水煎煮提取0.6小时,滤取煎液保温保存;
(3)将合并的三次煎液于72℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含 醇量达38%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含 醇量达68%,搅拌均匀,静置2.2小时,过滤取清液;
(4)使步骤(3)所得清液于57℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生 蜂蜜膏。
实施例6:制备养生蜂蜜膏
配方和制法分别参照实施例1~5进行,不同的仅是:果葡糖浆在步骤(4)中减压浓缩前向清液中添 加,得到5批养生蜂蜜膏样品。作为一种常规的药用辅料特别是通常作为调味剂,果葡糖浆在此步骤 阶段添加是本领域通用的生产实践。
试验例1:醇沉去除沉淀物量的考察
在实施例1~6的步骤(3)中,在经过两次醇沉、两次过滤后,将两次滤出的滤饼合并、干燥,称重, 比较实施例6进行的五个制备试验与相应的实施例1~5制备试验中滤饼干重(即,例如,将实施例6 之参照实施例1配方和制法进行的试验,与实施例1进行的试验,此相应的二者进行比较),以下式计 算实施例1~5中的沉淀去除率(%):
去除率(%)=[实施例1~5相应试验滤饼干重÷实施例6某试验滤饼干重]×100%
上述去除率(%)越大,则表示实施例1~5某试验中醇沉效果更好(相对于其实施例6相应试验而言)。 已经发现实施例1的沉淀去除率达146%,实施例2~5各自的沉淀去除率亦139~151%范围。这表明, 相对于实施例6而言,实施例1~5在步骤(3)中添加果葡糖浆能够更有效的实现醇沉除沉淀物的效果。
试验例2:测定绿原酸
绿原酸的含量测定方法:
照高效液相色谱法(中国药典2015年版四部通则0512)的规范测定;
色谱条件与系统适用性试验:以十八烷基硅烷键合硅胶为填充剂;以乙腈-0.4%磷酸溶液(13:87) 为流动相;检测波长为327nm。理论板数按绿原酸峰计算应不低于1000;
对照品溶液的制备:取绿原酸对照品适量,精密称定,置棕色量瓶中,加50%甲醇制成每1ml含 40μg的溶液,即得(10℃以下保存)。
供试品溶液的制备:取供试品适量(约相当于金银花药材0.5g),精密称定,置具塞锥形瓶中,精 密加入50%甲醇50ml,称定重量,超声处理(功率250W,频率35kHz)30分钟,放冷,再称定重量, 用50%甲醇补足减失的重量,摇匀,滤过,精密量取续滤液5ml,置25ml棕色量瓶中,加50%甲醇 至刻度,摇匀,即得。
测定法:分别精密吸取对照品溶液与供试品溶液各5~10μl注入液相色谱仪,测定,即得供试品中 绿原酸(C16H18O9)的含量。
对于实施例1~6的十次试验,测定投料金银花中绿原酸含量,根据金银花投料量计算绿原酸的理 论投料量,然后测定并计算最终所得养生蜂蜜膏成品中的绿原酸的收获量,以下式计算绿原酸的收获 率(%):
收获率(%)=[养生蜂蜜膏成品中的绿原酸收获量÷金银花中的绿原酸理论投料量]×100%
结果:实施例1~5的绿原酸收获率在84~90%范围,而实施例6的绿原酸收获率在59~65%范围, 与在醇沉过程中添加果葡糖浆的情形相比,在醇沉完毕后再加果葡糖浆时绿原酸收获率低20个百分点 以上,例如实施例1的绿原酸收获率为87%,而实施例6之参照实施例1试验的绿原酸收获率为64%, 相对而言收获率低23个百分点。
以上所揭露的仅为本发明的较佳实施例而已,当然不能以此来限定本发明的权利范围,因此依本 发明申请专利范围所作的等同变化,仍属本发明所涵盖的范围。
Claims (10)
1.具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜、秋梨、罗汉果、杏仁、白果、薄荷、金银花、甘草、枇杷叶、茶树花、雪莲培养物。
2.根据权利要求1的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨50~150克、罗汉果20~100克、杏仁10~50克、白果5~20克、薄荷5~20克、金银花20~100克、甘草5~30克、枇杷叶20~100克、茶树花50~250克、雪莲培养物20~100克。
3.根据权利要求1的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨80~120克、罗汉果20~50克、杏仁10~30克、白果5~10克、薄荷5~10克、金银花20~50克、甘草5~20克、枇杷叶20~50克、茶树花50~150克、雪莲培养物20~60克。
4.根据权利要求1的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、秋梨100克、罗汉果30克、杏仁20克、白果7.5克、薄荷7.5克、金银花30克、甘草10克、枇杷叶30克、茶树花100克、雪莲培养物40克。
5.根据权利要求1的养生蜂蜜膏,其中还包括果葡糖浆;在一个实施方案中,以每100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
6.根据权利要求1的养生蜂蜜膏,其是由包括如下步骤的方法制备得到的:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达35~45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达60~70%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使步骤(3)所得清液于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
7.制备权利要求1-6任一项所述养生蜂蜜膏的方法,该方法包括如下步骤:
(1)将秋梨、罗汉果、杏仁、白果、雪莲培养物用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、薄荷、金银花、甘草、枇杷叶、茶树花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达35~45%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达60~70%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使步骤(3)所得清液于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
8.权利要求1-6任一项所述养生蜂蜜膏在制备清热润肺止咳化痰平喘和调节人体机能的产品中的用途。
9.权利要求1-6任一项所述养生蜂蜜膏在制备解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力的产品中的用途。
10.权利要求1-6任一项所述养生蜂蜜膏在制备镇痛、抗炎、抗风湿、抑制血小板聚集、降血脂、改善血液循环、调节免疫系统、抗氧化、抗辐射、抗疲劳的产品中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810521657.0A CN108813501B (zh) | 2018-05-28 | 2018-05-28 | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810521657.0A CN108813501B (zh) | 2018-05-28 | 2018-05-28 | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108813501A true CN108813501A (zh) | 2018-11-16 |
CN108813501B CN108813501B (zh) | 2021-09-21 |
Family
ID=64146236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810521657.0A Active CN108813501B (zh) | 2018-05-28 | 2018-05-28 | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108813501B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112899217A (zh) * | 2021-01-29 | 2021-06-04 | 江西中医药大学 | 含药肝孵育液药理法及麻杏石甘汤含药肝孵育液制备方法 |
CN113854546A (zh) * | 2021-09-28 | 2021-12-31 | 湖南迪为农业科技有限公司 | 一种滋阴润肺羊肚菌蜜膏及其制备方法 |
CN116474056A (zh) * | 2023-03-24 | 2023-07-25 | 云南贝泰妮生物科技集团股份有限公司 | 一种改善呼吸道免疫力的植物蜜精及其制备工艺 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070286931A1 (en) * | 2001-03-19 | 2007-12-13 | Takasago International Corporation | Flavor-retention agent |
CN101779755A (zh) * | 2009-12-18 | 2010-07-21 | 芜湖盛开营养食品有限公司 | 一种蜂蜜膏 |
CN102551165A (zh) * | 2012-03-01 | 2012-07-11 | 霸王(广州)有限公司 | 一种清热润燥的中药四季养生饮料及其制备方法 |
CN103039774A (zh) * | 2013-01-04 | 2013-04-17 | 山东大学(威海) | 一种复方罗汉果蜜膏的加工方法 |
CN104522455A (zh) * | 2014-12-26 | 2015-04-22 | 北京蜜蜂堂生物医药股份有限公司 | 一种雪莲培养物蜂蜜膏及其制备方法 |
-
2018
- 2018-05-28 CN CN201810521657.0A patent/CN108813501B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070286931A1 (en) * | 2001-03-19 | 2007-12-13 | Takasago International Corporation | Flavor-retention agent |
CN101779755A (zh) * | 2009-12-18 | 2010-07-21 | 芜湖盛开营养食品有限公司 | 一种蜂蜜膏 |
CN102551165A (zh) * | 2012-03-01 | 2012-07-11 | 霸王(广州)有限公司 | 一种清热润燥的中药四季养生饮料及其制备方法 |
CN103039774A (zh) * | 2013-01-04 | 2013-04-17 | 山东大学(威海) | 一种复方罗汉果蜜膏的加工方法 |
CN104522455A (zh) * | 2014-12-26 | 2015-04-22 | 北京蜜蜂堂生物医药股份有限公司 | 一种雪莲培养物蜂蜜膏及其制备方法 |
Non-Patent Citations (1)
Title |
---|
杨海燕等: "醇沉对纯化金银花中绿原酸工艺的影响", 《中成药》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112899217A (zh) * | 2021-01-29 | 2021-06-04 | 江西中医药大学 | 含药肝孵育液药理法及麻杏石甘汤含药肝孵育液制备方法 |
CN113854546A (zh) * | 2021-09-28 | 2021-12-31 | 湖南迪为农业科技有限公司 | 一种滋阴润肺羊肚菌蜜膏及其制备方法 |
CN116474056A (zh) * | 2023-03-24 | 2023-07-25 | 云南贝泰妮生物科技集团股份有限公司 | 一种改善呼吸道免疫力的植物蜜精及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN108813501B (zh) | 2021-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104435775B (zh) | 一种中药保健酒及其制备方法 | |
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
CN101317615B (zh) | 一种银棘茶饮料及其制备方法 | |
CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN101543248B (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN110122803A (zh) | 一种诺丽果片及其制备方法 | |
CN106359720A (zh) | 一种清咽利喉和润肺清火的保健茶及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN102273679A (zh) | 一种饮料的制作方法 | |
CN101507800A (zh) | 金线莲和南瓜复合降血糖保健品及其制备方法 | |
CN105708970B (zh) | 一种具有降血糖功能的保健食品 | |
CN101491338A (zh) | 一种具有改善睡眠功能的营养食品及其制备方法 | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
CN104115960A (zh) | 一种鲜芦根凉茶饮料 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN103005439B (zh) | 一种苦瓜复方降脂口服液及其制备方法 | |
WO2023100764A1 (ja) | 気虚及び/又は血虚に関連する症状の予防、改善又は緩和のための組成物 | |
CN103960415A (zh) | 一种减肥保健凉茶及其制备方法 | |
CN1943448A (zh) | 竹汁银杏饮料及其生产方法 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Health preserving honey cream with functions of clearing heat, moistening lung, relieving cough, resolving phlegm, relieving asthma and regulating human body function Effective date of registration: 20220601 Granted publication date: 20210921 Pledgee: Zhangshu Shunyin Village Bank Co.,Ltd. Pledgor: JIANGXI TIANYUAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022980006899 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |